{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:17:45Z","timestamp":1785529065761,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00535-021-01801-3","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T04:31:30Z","timestamp":1624336290000},"page":"722-731","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Administration of a standard dose of vonoprazan fumarate delays gastric emptying in Japanese healthy adults: a prospective clinical trial"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5628-9662","authenticated-orcid":false,"given":"Kazuhiro","family":"Ota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimpei","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Iwatsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitoshi","family":"Hakoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kikutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Tawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Kanaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naofumi","family":"Osaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Takii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"1801_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/apt.15641","volume":"51","author":"T Takeuchi","year":"2020","unstructured":"Takeuchi T, Furuta T, Fujiwara Y, et al. Randomised trial of acid inhibition by vonoprazan 10\/20 mg once daily vs rabeprazole 10\/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study). Aliment Pharmacol Ther. 2020;51:534\u201343.","journal-title":"Aliment Pharmacol Ther"},{"key":"1801_CR2","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/jgh.14664","volume":"34","author":"H Miyazaki","year":"2019","unstructured":"Miyazaki H, Igarashi A, Takeuchi T, et al. Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: a systematic review. J Gastroenterol Hepatol. 2019;34:1316\u201328.","journal-title":"J Gastroenterol Hepatol"},{"key":"1801_CR3","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00535-019-01609-2","volume":"54","author":"Y Yokoya","year":"2019","unstructured":"Yokoya Y, Igarashi A, Uda A, et al. Cost-utility analysis of a \u201cvonoprazan-first\u201d strategy versus \u201cesomeprazole-or rabeprazole-first\u201d strategy in GERD. J Gastroenterol. 2019;54:1083\u201395.","journal-title":"J Gastroenterol"},{"key":"1801_CR4","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/j.1440-1746.2012.07121.x","volume":"27","author":"M Kusano","year":"2012","unstructured":"Kusano M, Hosaka H, Kawada A, et al. Development and evaluation of a modified Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease to distinguish functional dyspepsia from non-erosive reflux disease. J Gastroenterol Hepatol. 2012;27:1187\u201391.","journal-title":"J Gastroenterol Hepatol"},{"key":"1801_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/jgh.13970","volume":"33","author":"T Takeuchi","year":"2018","unstructured":"Takeuchi T, Takahashi Y, Kawaguchi S, et al. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor. J Gastroenterol Hepatol. 2018;33:623\u201330.","journal-title":"J Gastroenterol Hepatol"},{"key":"1801_CR6","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1007\/s10620-009-1076-x","volume":"55","author":"M Sanaka","year":"2010","unstructured":"Sanaka M, Yamamoto T, Kuyama Y. Effects of proton pump inhibitors on gastric emptying: a systematic review. Dig Dis Sci. 2010;55:2431\u201340.","journal-title":"Dig Dis Sci"},{"key":"1801_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000077391","volume":"69","author":"M Sanaka","year":"2004","unstructured":"Sanaka M, Yamamoto T, Ishii T, Kuyama Y. The Wagner-Nelson method can generate an accurate gastric emptying flow curve from CO2 data obtained by a 13C-labeled substrate breath test. Digestion. 2004;69:71\u20138.","journal-title":"Digestion"},{"key":"1801_CR8","unstructured":"Johnson LR, Ghishan FK, Wood JD et al (2012) Physiology of the gastrointestinal tract, 5th edn, Academic Press"},{"key":"1801_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/gutjnl-2014-308472","volume":"65","author":"J Tack","year":"2016","unstructured":"Tack J, Deloose E, Ang D, et al. Motilin-induced gastric contractions signal hunger in man. Gut. 2016;65:214\u201324.","journal-title":"Gut"},{"key":"1801_CR10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1365-2036.2005.02658.x","volume":"22","author":"J Tack","year":"2005","unstructured":"Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther. 2005;22:847\u201353.","journal-title":"Aliment Pharmacol Ther"},{"key":"1801_CR11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/45230","volume":"402","author":"M Kojima","year":"1999","unstructured":"Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656\u201360.","journal-title":"Nature"},{"key":"1801_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1053\/gast.2001.22158","volume":"120","author":"A Asakawa","year":"2001","unstructured":"Asakawa A, Inui A, Kaga T, et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology. 2001;120:337\u201345.","journal-title":"Gastroenterology"},{"key":"1801_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0014-2999(02)01432-2","volume":"440","author":"G Muccioli","year":"2002","unstructured":"Muccioli G, Tsch\u00f6p M, Papotti M, et al. Neuroendocrine and peripheral activities of ghrelin: Implications in metabolism and obesity. Eur J Pharmacol. 2002;440:235\u201354.","journal-title":"Eur J Pharmacol"},{"key":"1801_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jss.2005.08.003","volume":"130","author":"K Takachi","year":"2006","unstructured":"Takachi K, Doki Y, Ishikawa O, et al. Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy. J Surg Res. 2006;130:1\u20137.","journal-title":"J Surg Res"},{"key":"1801_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.surg.2005.11.015","volume":"139","author":"Y Doki","year":"2006","unstructured":"Doki Y, Takachi K, Ishikawa O, et al. Ghrelin reduction after esophageal substitution and its correlation to postoperative body weight loss in esophageal cancer patients. Surgery. 2006;139:797\u2013805.","journal-title":"Surgery"},{"key":"1801_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00595-014-1040-z","volume":"45","author":"S Takiguchi","year":"2015","unstructured":"Takiguchi S, Murakami K, Yanagimoto Y, et al. Clinical application of ghrelin in the field of surgery. Surg Today. 2015;45:801\u20137.","journal-title":"Surg Today"},{"key":"1801_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejphar.2013.01.035","volume":"702","author":"W Tsuchimochi","year":"2013","unstructured":"Tsuchimochi W, Kyoraku I, Yamaguchi H, et al. Ghrelin prevents the development of experimental diabetic neuropathy in rodents. Eur J Pharmacol. 2013;702:187\u201393.","journal-title":"Eur J Pharmacol"},{"key":"1801_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ajh\/hpt232","volume":"27","author":"Y Yano","year":"2014","unstructured":"Yano Y, Nakazato M, Toshinai K, et al. Circulating des-acyl ghrelin improves cardiovascular risk prediction in older hypertensive patients. Am J Hypertens. 2014;27:727\u201333.","journal-title":"Am J Hypertens"},{"key":"1801_CR19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1440-1681.2007.04624.x","volume":"34","author":"M Sanaka","year":"2007","unstructured":"Sanaka M, Nakada K, Nosaka C, et al. The Wagner-Nelson method makes the [13C]-breath test comparable to radioscintigraphy in measuring gastric emptying of a solid\/liquid mixed meal in humans. Clin Exp Pharmacol Physiol. 2007;34:641\u20134.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1801_CR20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s10620-008-0342-7","volume":"54","author":"M Sanaka","year":"2009","unstructured":"Sanaka M, Yamamoto T, Kuyama Y. Does rabeprazole enhance distension-induced gastric accommodation? Dig Dis Sci. 2009;54:416\u20138.","journal-title":"Dig Dis Sci"},{"key":"1801_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000484217","volume":"97","author":"Y Kojima","year":"2018","unstructured":"Kojima Y, Takeuchi T, Sanomura M, et al. Does the novel potassium-competitive acid blocker vonoprazan cause more hypergastrinemia than conventional proton pump inhibitors? A multicenter prospective cross-sectional study. Digestion. 2018;97:70\u20135.","journal-title":"Digestion"},{"key":"1801_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/gut.42.2.243","volume":"42","author":"HP Parkman","year":"1998","unstructured":"Parkman HP, UrbainKnight JLCLC, et al. Effect of gastric acid suppressants on human gastric motility. Gut. 1998;42:243\u201350.","journal-title":"Gut"},{"key":"1801_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1365-2036.2005.02528.x","volume":"22","author":"G Togus","year":"2005","unstructured":"Togus G, Earnest DL, Chen Y, et al. Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod. Aliment Pharmacol Ther. 2005;22:59\u201365.","journal-title":"Aliment Pharmacol Ther"},{"key":"1801_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000088465","volume":"72","author":"H Anjiki","year":"2005","unstructured":"Anjiki H, Sanaka M, Kuyama Y. Dual effects of rabeprazole on solid-phase gastric emptying assessed by the 13C-octanoate breath test. Digestion. 2005;72:189\u201394.","journal-title":"Digestion"},{"key":"1801_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000051891","volume":"63","author":"C Renou","year":"2001","unstructured":"Renou C, Carrie`reVille FE, et al. Effects of lansoprazole on human gastric lipase secretion and intragastric lipolysis in healthy human volunteers. Digestion. 2001;63:207\u201313.","journal-title":"Digestion"},{"key":"1801_CR26","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1111\/j.1440-1746.2006.04270.x","volume":"21","author":"Y Takahashi","year":"2006","unstructured":"Takahashi Y, Amano Y, Yuki T, et al. Influence of acid suppressants on gastric emptying: cross-over analysis in healthy volunteers. J Gastroenterol Hepatol. 2006;21:1664\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"1801_CR27","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/00365520802105110","volume":"43","author":"A Franke","year":"2008","unstructured":"Franke A, Hepp C, Harder H, et al. Esomeprazole reduces gastroesophageal reflux after beer consumption in healthy volunteers. Scand J Gastroenterol. 2008;43:1425\u201331.","journal-title":"Scand J Gastroenterol"},{"key":"1801_CR28","first-page":"84","volume":"53","author":"BW Kim","year":"2009","unstructured":"Kim BW, Lee BI, Kim HK, et al. Influence of long-term gastric acid suppression therapy on the expression of serum gastrin, chromogranin A, and ghrelin. Korean J Gastroenterol. 2009;53:84\u20139.","journal-title":"Korean J Gastroenterol"},{"key":"1801_CR29","first-page":"62","volume":"59","author":"M Arai","year":"2012","unstructured":"Arai M, Matsumura T, Tsuchiya N, et al. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. Hepatogastroenterology. 2012;59:62\u20136.","journal-title":"Hepatogastroenterology"},{"key":"1801_CR30","doi-asserted-by":"publisher","first-page":"e13319","DOI":"10.1111\/nmo.13319","volume":"30","author":"K Tominaga","year":"2018","unstructured":"Tominaga K, Sakata Y, Kusunoki H, et al. Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: a randomized clinical trial (the DREAM study). Neurogastroenterol Motil. 2018;30:e13319.","journal-title":"Neurogastroenterol Motil"},{"key":"1801_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/gut.2004.038737","volume":"54","author":"A Asakawa","year":"2005","unstructured":"Asakawa A, Inui A, Fujimiya M, et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut. 2005;54:18\u201324.","journal-title":"Gut"},{"key":"1801_CR32","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1210\/en.2015-1561","volume":"156","author":"K Kuroda","year":"2015","unstructured":"Kuroda K, Hequing H, Mondal A, et al. Ghrelin Is an essential factor for Motilin-induced gastric contraction in Suncus murinus. Endocrinology. 2015;156:4437\u201347.","journal-title":"Endocrinology"},{"key":"1801_CR33","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/MEG.0000000000001868","volume":"32","author":"A Panarese","year":"2020","unstructured":"Panarese A, Romiti A, Iacovazzi PA, et al. Relationship between atrophic gastritis, serum ghrelin and body mass index. Eur J Gastroenterol Hepatol. 2020;32:1335\u201340.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1801_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1046\/j.1365-2036.1998.00349.x","volume":"12","author":"BE Schenk","year":"1998","unstructured":"Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection. Aliment Pharmacol Ther. 1998;12:605\u201312.","journal-title":"Aliment Pharmacol Ther"},{"key":"1801_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00535-003-1297-2","volume":"39","author":"K Miyasaka","year":"2004","unstructured":"Miyasaka K, Ohta M, Kanai S, et al. Enhanced gastric emptying of a liquid gastric load in mice lacking cholecystokinin-B receptor: a study of CCK-A, B, and AB receptor gene knockout mice. J Gastroenterol. 2004;39:319\u201323.","journal-title":"J Gastroenterol"},{"key":"1801_CR36","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1136\/gut.10.9.723","volume":"10","author":"JJ Misiewicz","year":"1969","unstructured":"Misiewicz JJ, Waller SL, Holdstock DJ. Gastrointestinal motility and gastric secretion during intravenous infusions of gastrin II. Gut. 1969;10:723\u20139.","journal-title":"Gut"},{"key":"1801_CR37","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/JCI110818","volume":"71","author":"M Feldman","year":"1983","unstructured":"Feldman M, Richardson CT, Walsh JH. Sex-related differences in gastrin release and parietal cell sensitivity to gastrin in healthy human beings. J Clin Invest. 1983;71:715\u201320.","journal-title":"J Clin Invest"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-021-01801-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-021-01801-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-021-01801-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T06:40:56Z","timestamp":1699166456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-021-01801-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1801"],"URL":"https:\/\/doi.org\/10.1007\/s00535-021-01801-3","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"25 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kazuhide Higuchi received research grants and speaker fees from Otsuka Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Company Ltd. The other authors declare no conflict of interest associated with this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}